Skip to main content
NOVOGENE CO., LTD. logo

NOVOGENE CO., LTD. — Investor Relations & Filings

Ticker · 688315 ISIN · CNE1000052X3 Shanghai Stock Exchange Professional, scientific and technical activities
Open in API
Filings indexed 558 across all filing types
Latest filing 2021-05-25 Regulatory Filings
Country CN China
Listing Shanghai Stock Exchange 688315

About NOVOGENE CO., LTD.

https://www.novogene.com

Novogene Co., Ltd. is a global provider of genomic services and solutions, specializing in next-generation sequencing (NGS) and bioinformatics analysis. The company offers a comprehensive suite of services, including whole genome sequencing, transcriptomics, epigenomics, and metagenomics, alongside specialized solutions for single-cell analysis and clinical diagnostics. Utilizing advanced high-throughput sequencing platforms and proprietary bioinformatics pipelines, Novogene supports research across diverse fields such as human health, agriculture, and environmental science. The organization serves a broad client base encompassing academic institutions, pharmaceutical companies, and biotechnology firms. With a focus on data quality and technical expertise, Novogene facilitates large-scale genomic studies and precision medicine initiatives through its network of high-capacity laboratories and integrated data management systems.

Recent filings

Filing Released Lang Actions
诺禾致源关于预计2021年度日常关联交易的公告
Regulatory Filings Classification · 95% confidence The document is an announcement regarding the company's expected related party transactions for the year 2021. It includes details about the nature of the transactions, approval procedures by the board, independent directors' opinions, and the impact on the company. It does not contain financial statements or comprehensive financial data but rather focuses on disclosure of related party transactions and compliance with regulatory requirements. The document is a regulatory announcement about related party transactions rather than a full financial report or audit. Therefore, it fits best under Regulatory Filings (RNS). The document length is 4344 characters, which is relatively short and consistent with an announcement rather than a full report.
2021-05-25 Chinese
诺禾致源关于第二届监事会第九次会议决议公告
Regulatory Filings Classification · 95% confidence The document is a formal announcement of resolutions passed at the 9th meeting of the 2nd Supervisory Board of Beijing Nuohe Zhiyuan Technology Co., Ltd. It includes details on the approval of the 2020 Supervisory Board work report, financial settlement and budget reports, profit distribution plan, related party transactions, supervisory board remuneration, bank loan plans, and use of idle raised funds. The document is a meeting resolution announcement rather than a full financial report or detailed management discussion. It is not an annual report, audit report, or earnings release. It is also not a proxy statement or voting result declaration. The document is a regulatory announcement of board meeting decisions, fitting best under Regulatory Filings (RNS). The document length is short (1907 characters), and it contains meeting resolutions rather than full reports or presentations.
2021-05-25 Chinese
诺禾致源独立董事关于第二届董事会第十五次会议相关事项的事前认可意见
Board/Management Information Classification · 95% confidence The document is a formal opinion from independent directors regarding agenda items for the company's second board meeting, specifically about the appointment of the 2021 audit firm and anticipated related party transactions. It references compliance with company law, stock exchange listing rules, and company bylaws. The document is a pre-approval or endorsement opinion related to board meeting matters, not a full audit report or annual report. It does not contain financial statements or detailed audit results but rather an independent directors' opinion on proposed board resolutions. This fits best under Board/Management Information (MANG), which covers announcements related to board decisions and management matters.
2021-05-25 Chinese
诺禾致源2020年年度审计委员会履职报告
Audit Report / Information Classification · 95% confidence The document is titled as the '2020 Annual Audit Committee Performance Report' of Beijing Novogene Technology Co., Ltd. It details the audit committee's members, meetings held in 2020, their supervision and evaluation of the external audit firm, internal audit guidance, review of financial reports, assessment of internal controls, and coordination between management and auditors. The document is a report on the audit committee's activities and oversight related to the company's audit processes for the year 2020. It is not the full annual report (10-K) nor a standalone audit report by the auditors, but rather a committee's report on their audit oversight duties. This fits the definition of an Audit Report / Information (AR) filing, which includes audit reports and related information excluding full annual reports. The document length is under 5,000 characters and contains substantive content, not just an announcement or certification, so it is not RPA or RNS. Therefore, the correct classification is AR with high confidence. FY 2020
2021-05-25 Chinese
诺禾致源2020年年度独立董事述职报告
Board/Management Information Classification · 95% confidence The document is titled as the "2020 Annual Independent Directors' Report" of Beijing Nuohe Zhiyuan Technology Co., Ltd. It details the independent directors' activities, attendance at board and committee meetings, oversight of company governance, review of financial and operational matters, and overall evaluation for the year 2020. The content focuses on the independent directors' duties and their report on their work during the year, rather than presenting full financial statements or audit results. It is a formal report by independent directors, which is a type of management or governance report but does not constitute a full Annual Report (10-K) or Audit Report (AR). It is not a short announcement or certification, but a substantive report on independent directors' work. Therefore, the best fitting category is Board/Management Information (MANG), which covers announcements or reports related to board or senior management activities, including independent directors' reports.
2021-05-25 Chinese
中信证券股份有限公司关于北京诺禾致源科技股份有限公司使用部分暂时闲置募集资金进行现金管理的核查意见
Regulatory Filings Classification · 95% confidence The document is a detailed verification opinion from CITIC Securities regarding the use of temporarily idle raised funds by Beijing Novogene Technology Co., Ltd. for cash management. It references regulatory approvals, fund raising details, investment projects, cash management purposes, risk control measures, and internal decision procedures. The document is not a financial report itself but a regulatory compliance and verification statement related to the use of raised funds. It does not contain financial statements or earnings data, nor is it a simple announcement of a report. It fits best under Regulatory Filings (RNS) as it is a compliance and regulatory disclosure document that does not fit other specific categories.
2021-05-25 Chinese

Browse filings by year

6 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.